ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Share Fallers
Why Australian Ethical, Northern Star, ResMed, & TPG Telecom are dropping lower
Share Market News
ASX 200 rises 0.7%, ResMed result disappoints
Share Market News
ASX 200 up 0.6%: ResMed & Scentre tumble, big four banks rise
Share Fallers
Why Advance NanoTek, ELMO Software, ResMed, & Scentre shares are dropping lower
Share Market News
ResMed share price lower despite delivering strong growth in FY 2020
Share Market News
5 things to watch on the ASX 200 on Thursday
Share Market News
ResMed and 1 other 5-star ASX 200 share to buy in August
Share Market News
This is the only ASX sector tipped to report earnings growth this reporting season
Growth Shares
Why I would buy NEXTDC and these stellar ASX growth shares
⏸️ Investing
7 ASX shares to watch this reporting season
⏸️ ASX Shares
I would buy ResMed and these ASX blue chip shares in August
Growth Shares
Add these ASX growth shares to your portfolio in August
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
